The symptomatic, electrocardiographic, and haemodynamic effects of two adrenergic beta-blocking drugs, oxprenolol and propranolol, have been compared in equipotent intravenous doses in six patients with uncomplicated angina pectoris during treadmill exercise. The method of comparison included double-blind assessment and analysis with placebo control and randomized serial comparison in each patient. Both drugs produced an equal amelioration in symptoms in most of the patients. This was closely correlated with improvement in the electrocardiographic changes and a significant reduction in the exercising heart rate and systemic arterial pressure. This method of double-blind combined subjective and objective assessment carries distinct advantages in the comparative assessment of drug treatments in angina pectoris.
Introduction
Though a number of adrenergic beta-blocking drugs are available for the symptomatic treatment of severe angina pectoris there is little information on their comparative effectiveness. This report concerns a comparative study of the symptomatic, electrocardiographic, and circulatory effects of two such drugs, oxprenolol and propranolol, in patients with angina pectoris.
Patients and Methods
Six men aged 39 to 58 (mean 47) years with uncomplicated angina pectoris were studied. Their average weight was (range 58-89) kg. None were obese, hypertensive, or diabetic, none had hyperlipidaemia, and none had had a previous myocardial infarction or history of other heart disease. In all cases the angina was induced solely and repeatedly by exercise; the length of angina history ranged from eight months to five years. No patient had received previous treatment other than glyceryl trinitrate.
The resting electrocardiogram was normal in all patients; during treadmill exercise the S-T segment in the standard and chest leads V 4-6 was depressed by more than 0-05 mV (1 mm) in all cases during anginal pain. The chest radiograph was normal and the cardiothoracic ratio was less than 50 % in all patients. All had normal left ventricular function at rest but evidence of severe reversible impairment of left ventricular performance during exercise as previously described . 
Physician
The purpose, investigative programme, and possible clinical benefits of the study were discussed with each patient; without inducement all consented willingly to the series of studies.
DESIGN OF INVESTIGATION
The speed and slope of the treadmill was adjusted so that in each patient anginal pain did not occur before the third minute of exercise and all were able to complete six minutes of continuous exercise; a reproducible end-point was thus achieved. The patient was also trained to indicate the onset and severity of his pain by a finger-operated light-switch. Pain was arbitrarily graded as mild, moderate, or severe; "mild" pain was defined as early discomfort or tightness of the chest, "moderate" as a feeling of severe constriction but not severe enough to prevent walking, and "severe" was categorized as of that severity which urgently required the patient to stop exercise. Precautions were taken to control factors which might have induced erroneous changes in exercise tolerance. The laboratory temperature was controlled, apprehension among patients was reduced by familiarization with the technique, the studies were carried out at the same time each day and not earlier than one hour after a light carbohydrate meal, and only if the patient had not had an attack of angina during the previous four hours. After the reproducibility of each patient's symptoms had been established, the definite studies were carried out at the same time on alternate days.
Each study consisted of equal six-minute contiguous periods of sitting, standing, walking, standing, and sitting. Studies were carried out without injection, after intravenous saline injection (10 ml), oxprenolol (0-2 mg/kg body weight), or propranolol (0-2 mg/kg). These doses of oxprenolol and propranolol have been shown to result in equal and complete blockade of the heart rate response to infusion of 20 ,ug of isoprenaline per minute and to produce the maximum effect on the heart rate response to supine leg exercise, Valsalva manoeuvre, and ingestion of glyceryl trinitrate Majid et al., 1971) . The placebo, oxprenolol, and propranolol studies were all started 10 minutes after the intravenous injection. The order was randomized and the content of the injection was unknown to the doctor and patient. Electrocardiographic and systemic arterial pressure records were recorded continuously throughout each study so that the exact time of the S-T depression could be determined. The records were analysed by observers who had no knowledge of the drug given. The study was, therefore, double-blind in design and analysis, placebo-controlled, randomized in order, and each patient served serially as his own control.
TECHNIQUES, MEASUREMENTS, AND STATISTICAL METHODS
Electrocardiographic chest lead V5 was recorded from an adhesive-disc electrode. The linear S-T segment depression from the isoelectric line was measured immediately after the S-T junction and averaged over five complexes during each minute of study, as previously described . Measurements were averaged throughout each period of rest and for the final two minutes of exercise during treadmill walking. Systemic arterial pressure was measured in the aorta from a nylon catheter (55 by 01 cm) introduced percutaneously into a brachial artery. The E.C.G. and systemic arterial pressure were recorded continuously at 5 and 125 mm/sec alternately on an ultraviolet recorder with 32-cm focal length galvanometers. Mean systolic and diastolic pressures were measured by planimetry from the aortic pressure pulse . Electrocardiographic, heart rate, and systemic arterial pressure measurements were averaged over the final four minutes of each six-minute period except during walking, when the measurements were averaged over the final two minutes of exercise. Probability of significance of differences was calculated from comparison of test and control paired values in the same individual (Fisher, 1946) .
Results

SYMPTOMS
No patient had pain during sitting or standing in any of the four studies. In the control study all six patients developed mild pain during treadmill walking ( Fig. 1) , which progressed to moderate intensity in all and to severe pain in four. After saline injection and at the same level of exertion all the patients developed both mild and moderate pain which progressed to severe in three. After both intravenous oxprenolol and propranolol pain was abolished in two patients who had previously developed severe pain at the same level of exertion. The remaining four still developed mild pain which progressed to moderate in three and to severe in one after each drug. The changes in time course of the pain were significantly modified by both drugs (see Table) ; there was no significant difference between the two drugs with respect to the delay in 153 time of onset, the hastened time of recovery, or the total duration of pain.
ELECTROCARDIOGRAPHIC CHANGES
There was no significant S-T depression during the initial sitting or standing periods in any patient in any of the four studies. During the final two minutes of exercise in the control study, when all patients had anginal pain, the average S-T depression was significantly greater than at rest (2 5 mm; P>O0O1) (Fig, 2,  Table) . After saline injection the time course and extent of the S-T segment depression (2-4 mm) was not significantly different from the changes during the control study. After both intravenous oxprenolol and propranolol the time of onset of the S-T depression, its maximum extent at the same level of exertion as in the control study, and its time of resolution after exercise were all significantly reduced at the 2 , level of confidence or greater; there was no statistically significant difference between the effects of the two drugs.
There were no other significant electrocardiographic changes; the average peak height of the T wave during exercise was not significantly changed by either oxprenolol or propranolol. The electrocardiographic S-T segment changes correlated closely with the improvement in symptoms. In two patients in whom the symptoms were abolished by oxprenolol and propranolol the S-T segment depression was reduced from 3'2 and 2-9 mm respectively in the control study to 1-9 and 1-3 respectively after propranolol. In the single patient who had no relief from drugs the S-T segment depression was 2 5, 2.5, and 2-9 mm in the control, oxprenolol, and propranolol studies respectively. The three remaining patients who experienced partial relief of symptoms after the two beta-blocking drugs all showed a reduction in S-T segment depression of 1-5 mm or greater compared with the measurement in the control or placebo study.
HEART RATE, SYSTOLIC, AND DIASTOLIC PRESSURES In the control study the average standing heart rate was 85/ min; this increased to an average of 134/min during the final two minutes of exercise (Fig. 3 Table) . The from those in the control study. After oxprenolol the average standing heart rate at rest was 78/mn (P<002) and during exercise 104/mmn (P<0 01). After propranolol the average standing and walking heart rates were 76/mmn (P<002) and 103/min (P<0 001) respectively. There was no significant differences between the effects of the two drugs on the standing and walking heart rates. In the control study the average mean systolic and diastolic pressures during standing were 114 and 87 mm Hg respectively, and during the final two minutes of treadmill exercise 127 and 94 mm Hg respectively. There was no statistically significant difference between these values in the control and placebo studies. After oxprenolol there was no significant change in the average standing pressures but there was a significant reduction in the average mean systolic pressure during exercise to 113 mm Hg (P<c0 01) and a significant reduction in the mean diastolic pressure to 79 mm Hg (P<0-02). After propranolol there was no significant change in the standing pressures but the mean systolic pressure during walking was significantly reduced to 110 mm Hg (P<0.01) and the mean diastolic pressure to 77 mm Hg (P<0.01).
The average left ventricular systolic pressure-time product during walking was unchanged after placebo, oxprenolol, or propranolol.
Discussion
The findings in this study showed that both beta-blocking drugs significantly delayed the onset, duration, and intensity of the exercise-induced pain in five of the six patients. This improvement in symptoms was accompanied by significant improvement in the electrocardiogram and closely correlated with simultaneous reductions in the heart rate and mean systolic pressure; there was no significant change in the systolic pressure-time product during angina after either drug. There were no significant differences between the subjective or objective effects of the two beta-blocking drugs. These results are given added validity by the fact that each patient was trained to an extent where the symptoms were reliably reproduced, every attempt was made to maintain identical conditions during each study, they were double-blind in both design and analysis, placebo controlled, randomized in order, and serially compared in each patient.
This study was not designed to give information on the relative effectiveness of beta-blocking drugs in angina; the small number of patients studied absolutely precludes any reliable inferences to be made on this point. Neither was it designed to distinguish those patients who could be expected to benefit from beta-blocking therapy.
Most studies showing improvement in anginal symptoms afforded by beta-blocking drugs have been open, single-blind, or double-blind assessments of symptomatic improvement. Few have been concerned with the correlated objective electrocardiographic and haemodynamic measurements and none seem to have been concerned to establish the degree of beta-blockade in the patients under study. Stern and Eisenberg (1969) showed that intravenous propanolol (10 mg) had no effect on the S-T segment of resting normal subjects. Furberg (1967) and Biorck et al. (1968) stated that the S-T segment was unchanged during exercise but that there was a more rapid resolution of the changes after stopping work. However, both of these studies may be criticized from a dose-response aspect. The patients in the study of Furberg were restudied one hour after an oral dose of 5-20 mg; the reduction in heart rate or degree of betablockade after this small dose of drug was not stated. Biorck et al. used only 5 mg of propranolol intravenously (about 0-07 mg/kg), a dose that produces only a relatively small degree of beta-blockade . Gianelly et al. (1960 , in directly relevant studies on 11 men in whom anginal pain was accompanied by typical S-T changes during treadmill exercise, showed a significant reduction in the S-T segment depression after intravenous propranolol (0.15 mg/kg). Prichard et al. (1970) reported similar electrocardiographic findings during bicycle exercise in angina patients after both propanolol and oxprenolol. As S-T segment depression is a relatively reliable objective clinical index of myocardial ischaemia in angina pectoris, the correlation of symptomatic and electrocardiographic changes is a potentially valuable objective measure of the efficacy of this type of antianginal treatment.
The improvement in symptoms in these patients is probably predominantly related to the decreased heart rate and reduced systemic arterial pressure. These two factors correlate closely and directly with myocardial oxygen consumption (Evans, 1917; Cohn and Steele, 1935; Sarnoff et al., 1958) and the onset of pain in angina patients (Robinson, 1967; Sharma et al., 1971) . Withdrawal of sympathetic drive to the ventricles also reduces the speed of ventricular contraction, which may further reduce myocardial oxygen consumption (Sonnenblick et al., 1965a) . Though it has been shown that the left ventricular volume and end-diastolic pressure are increased both at rest and during exercise in the non-ischaemic heart after beta-blockade (Sonnenblick et al., 1965b; Chamberlain, 1966; Gander et al., 1966; Majid et al., 1970) , left ventricular filling pressure is often not increased during exercise in anginal patients after betablockade (Dwyer et al., 1968; Astrom, 1968; Sharma et al., 1970) , probably due to the sparing effect of the reduced rate, pressure, and speed of contraction on the left ventricular myocardial oxygen consumption. By reducing myocardial oxygen demand and coronary blood flow requirements these factors outweigh any direct increase in coronary vascular resistance due to beta-blockade (Folle and Aviado, 1965; Klocke et al., 1965; McKenna et al., 1966; Whitsitt and Lucchesi, 1967 This work was assisted by a grant from the Wellcome Foundation.
Requests for reprints should be addressed to Dr. S. H. Taylor, Department of Medicine, the General Infirmary, Leeds LS1 3EX. Introduction A positive Kveim reaction has in the past been regarded as highly specific for sarcoidosis (Siltzbach, 1967) . However, in a recent study Kveim tests were made with a carefully validated test suspension prepared from a sarcoid spleen (K12) in a series of 74 patients with definite or probable Crohn's disease (Mitchell, Cannon, Dyer, Hinson, and Willoughby, 1970) . Microscopical readings of the biopsy specimens showed that 38 (51 %) had a positive Kveim test. Moreover, 12 out of 19 patients with clinically definite or histologically confirmed Crohn's disease had a positive reaction both to K12 and to another extensively validated test suspension (Hurley) prepared from a different sarcoid spleen.
The nature of the Kveim reaction is not understood, but it seems probable that it may represent a special class of reaction, possibly a "delayed, delayed-type" of cell-mediated cutaneous hypersensitivity response (Hart and Rees, 1967) . Since the leucocyte migration test is of proved value as an in-vitro correlate of cell-mediated hypersensitivity (Soborg and Bendixen, 1967; Bendixen and S0borg, 1969) and had already been found to mediate a specific response to sarcoid spleen suspensions in sarcoidosis (Hardt and Wanstrup, 1969) , it was decided to investigate the potential role of sarcoid and of normal spleen suspensions in the in-vitro inhibition of leucocytes in Crohn's disease, and to include for comparison similar tests in patients with ulcerative colitis and other conditions.
